Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy.
Structures and the oxygen deficiency of tetragonal and monoclinic zirconium oxide nanoparticles.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy.
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am J Med. 2006 Aug; 119(8):639-46.
View in:
PubMed
subject areas
Antibodies
Humans
Lung Diseases
Tumor Necrosis Factor-alpha
authors with profiles
Gokhan Mutlu